Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis

Prenatal Diagnosis

Volumn 26, Issue 10, 2006, Pages 906-916

  Saker, Ali ^a,b,c   Benachi, Alexandra ^c   Bonnefont, Jean Paul ^c   Munnich, Arnold ^c   Dumez, Yves ^c   Lacour, Bernard ^c   Paterlini Brechot, Patrizia ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Allele drop out (ADO); Circulating fetal cells; Cystic fibrosis; Genetic analyses; Non invasive prenatal diagnosis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FETUS; FETUS CELL; FETUS CIRCULATION; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENOME; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MUTATIONAL ANALYSIS; NON INVASIVE MEASUREMENT; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGENY; SHORT TANDEM REPEAT; TROPHOBLAST; VALIDATION STUDY;

ALLELES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FETUS; GENETIC SCREENING; HUMANS; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33750559624     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1524     Document Type: Article

References (51)

1. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. 1999. Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies. Am J Med Genet 85: 66-75.
2. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH. 2004. Assessment of efficacy of cell separation techniques used in the enrichment of foetal erythroblasts from maternal blood: triple density gradient vs. single density gradient. Clin Lab Haematol 26: 123-128.
3. Balinsky W, Zhu CW. 2004. Pediatric cystic fibrosis: evaluating costs and genetic testing. J Pediatr Health Care 18: 30-34.
4. Beroud C, Karliova M, Bonnefont JP, et al. 2003. Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells. Lancet 361: 1013-1014.
5. Bianchi DW. 1999. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol 105: 574-583.
6. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. 1996. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93: 705-708.
7. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. 1997. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61: 822-829.
8. Bianchi DW, Simpson JL, Jackson LG, et al. 2002. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 22: 609-615.
9. Bohmer RM, Stroh HP, Johnson KL, LeShane ES, Bianchi DW. 2002. Fetal cell isolation from maternal blood cultures by flow cytometric hemoglobin profiles. Results of a preliminary clinical trial. Fetal Diagn Ther 17: 83-89.
10. Chen HP, Wang TR, Xu JP, Xu XY, Dangol SD, He GF. 2004. Fetal origin of single nucleated erythroblasts and free DNA in the peripheral blood of pregnant women. Int J Gynaecol Obstet 85: 1-5.
11. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. 2002. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
12. Ciarleglio LJ, Bennett RL, Williamson J, Mandell JB, Marks JH. 2003. Genetic counseling throughout the life cycle. J Clin Invest 112: 1280-1286.
13. Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. 2001. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn 21: 1070-1074.
14. Costa JM, Giovangrandi Y, Ernault P, et al. 2002. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 119: 255-260.
15. de Graaf IM, Jakobs ME, Leschot NJ, Ravkin I, Goldbard S, Hoovers JM. 1999. Enrichment, identification and analysis of fetal cells from maternal blood: evaluation of a prenatal diagnosis system. Prenat Diagn 19: 648-652.
16. Fink L, Collins FS. 1997. The human genome project: view from the National Institutes of Health. J Am Med Women's Assoc 52: 4-7-15.
17. Garvin AM, Holzgreve W, Hahn S. 1998. Highly accurate analysis of heterozygous loci by single cell PCR. Nucleic Acids Res 26: 3468-3472.
18. Gilbert F. 2001. Cystic fibrosis carrier screening: steps in the development of a mutation panel. Genet Test 5: 223-227.
19. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, et al. 2002. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 22: 946-948.
20. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, et al. 2003. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 23: 232-234.
21. Griffin DK, Ferguson-Smith MA. 1999. Diagnosis of sex and cystic fibrosis status in fetal erythroblasts isolated from cord blood. Prenat Diagn 19: 172-174.
22. Hahn S, Garvin AM, Di Naro E, Holzgreve W. 1998. Allele dropout can occur in alleles differing by a single nucleotide and is not alleviated by preamplification or minor template increments. Genet Test 2: 351-355.
23. Hahn S, Zhong XY, Troeger C, Burgemeister R, Cloning K, Holzgreve W. 2000. Current applications of single-cell PCR. Cell Mol Life Sci 57: 96-105.
24. Kerem B, Rommens JM, Buchanan JA, et al. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073-1080.
25. Kolialexi A, Tsangaris GT, Antsaklis A, Mavrou A. 2004. Fetal cells in maternal plasma are found in a late state of apoptosis. Prenat Diagn 24: 719-721.
26. Koumantaki Y, Sifakis S, Dragatis G, et al. 2001. Microsatellite analysis provides efficient confirmation of fetal trophoblast isolation from maternal circulation. Prenat Diagn 21: 566-570.
27. Krabchi K, Gadji M, Samassekou O, Gregoire MC, Forest JC, Drouin R. 2006. Quantification of fetal nucleated cells in maternal blood of pregnant women with a male trisomy 21 fetus using molecular cytogenetic techniques. Prenat Diagn 26: 28-34.
28. Krabchi K, Gros-Louis F, Yan J, et al. 2001. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 60: 145-150.
29. Krabchi K, Lavoie J, Coullin P, et al. 2004. From the conception of the PRINS to its coronation. Med Sci (Paris) 20: 465-473.
30. Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. 2004. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn 24: 896-898.
31. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. 2005. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293: 843-849.
32. Lo YM, Tein MS, Lau TK, et al. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775.
33. Martel-Petit V, Petit C, Marchand M, et al. 2001. Use of the Kleihauer test to detect fetal erythroblasts in the maternal circulation. Prenat Diagn 21: 106-111.
34. Nagy B, Ban Z, Papp Z. 2005. The DNA isolation method has effect on allele drop-out and on the results of fluorescent PCR and DNA fragment analysis. Clin Chim Acta 360: 128-132.
35. Nasis O, Thompson S, Hong T, et al. 2004. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 50: 694-701.
36. Oosterwijk JC, Knepfle CF, Mesker WE, et al. 1998. Strategies for rare-event detection: an approach for automated fetal cell detection in maternal blood. Am J Hum Genet 63: 1783-1792.
37. Orsetti B, Lefort G, Boulot P, Andreo B, Pellestor F. 1998. Fetal cells in maternal blood: the use of primed in situ (PRINS) labelling technique for fetal cell detection and sex assessment. Prenat Diagn 18: 1014-1022.
38. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. 1995. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21: 313-321.
39. Piyamongkol W, Bermudez MG, Harper JC, Wells D. 2003. Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. Mol Hum Reprod 9: 411-420.
40. Rowley PT, Loader S, Kaplan RM. 1998. Prenatal screening for cystic fibrosis carriers: an economic evaluation. Am J Hum Genet 63: 1160-1174.
41. Schmidtke J. 1998. A commentary on the NIH consensus development statement 'genetic testing for cystic fibrosis'. Community Genet 1: 53-56.
42. Sitar G, Brambati B, Baldi M, et al. 2005. The use of non-physiological conditions to isolate fetal cells from maternal blood. Exp Cell Res 302: 153-161.
43. van Wijk IJ, van Vugt JM, Mulders MA, Konst AA, Weima SM, Oudejans CB. 1996. Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. Am J Obstet Gynecol 174: 871-878.
44. von Eggeling F, Michel S, Gunther M, Schimmel B, Claussen U. 1997. Determination of the origin of single nucleated cells in maternal circulation by means of random PCR and a set of length polymorphisms. Hum Genet 99: 266-270.
45. Vona G, Sabile A, Louha M, et al. 2000. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterisation of circulating tumor cells. Am J Pathol 156: 57-63.
46. Vona G, Beroud C, Benachi A, et al. 2002. Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol 160: 51-58.
47. Voullaire L, Ioannou P, Nouri S, Williamson R. 2001. Fetal nucleated red blood cells from CVS washings: an aid to development of first trimester non-invasive prenatal diagnosis. Prenat Diagn 21: 827-834.
48. Watson MS, Cutting GR, Desnick RJ, et al. 2004. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6: 387-391.
49. Yang YH, Kim SH, Yang ES, et al. 2003. Prenatal diagnosis of fetal trisomy 21 from maternal peripheral blood. Yonsei Med J 44: 181-186.
50. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N. 1992. Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci USA 89: 5847-5851.
51. Zimmer N, Gotten E, Kraus J, Zang KD, Henn W. 1993. Immunophenotyping of mitotic cells from long-term cultures of chorionic villi. Hum Genet 91: 317-320.